Symbol: |
CECR2
|
Description: |
cat eye syndrome chromosome region, candidate 2 [Source:HGNC Symbol;Acc:1840]
|
Location: |
Chr22:17840837-18033845[+]
|
CRmiRSNP:
~ Export ~
|
Records:38
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:3 Current:1
[First] [Prev]  Next Last 
|
Compound:
~ Export ~
|
Records:116
Gene |
Compound |
Gen_sig |
Exp_pattern |
CECR2 |
NSC 715556 |
0.025 |
Down |
CECR2 |
NSC 715648 |
0.004 |
Up |
CECR2 |
NSC 715755 |
0.003 |
Down |
CECR2 |
NSC 716426 |
0.019 |
Down |
CECR2 |
NSC 717167 |
0.018 |
Down |
CECR2 |
Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- |
0.014 |
Down |
CECR2 |
NSC 718652 |
0.026 |
Up |
CECR2 |
11-(5'-Bromopentylidine)-5,6-dihydro-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-5-oxo-11H-indeno[1,2-c]isoquinoline |
0.009 |
Down |
CECR2 |
NSC 719715 |
0.009 |
Down |
CECR2 |
7-chloro-3-(4-fluorophenyl)-5-methylthiazolo[4,5-d]pyrimidin e-2(3H)-thione |
0.004 |
Down |
CECR2 |
NSC 722876 |
0.039 |
Down |
CECR2 |
ARTEMISININ DIMER HEMISUCCINATE |
0.047 |
Up |
CECR2 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.035 |
Down |
CECR2 |
NSC 732956 |
0.004 |
Down |
CECR2 |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.017 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:7
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:60
Total:4 Current:1
[First] [Prev]  Next Last 
|